Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anal Cancer Stage II”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT01408407
What this trial is testing

Alkagin Paste in the Prevention of Radiation Dermatitis

Who this might be right for
Anus NeoplasmsRectal NeoplasmsUrogenital Neoplasms
Sir Mortimer B. Davis - Jewish General Hospital 2
Testing effectiveness (Phase 2)Looking for participantsNCT05040815
What this trial is testing

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Who this might be right for
Anal Canal Cancer
AHS Cancer Control Alberta 45
Testing effectiveness (Phase 2)Looking for participantsNCT06493019
What this trial is testing

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Who this might be right for
Anal Cancer
Dustin Deming 23
Testing effectiveness (Phase 2)WithdrawnNCT04499352
What this trial is testing

Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Who this might be right for
Anal Canal Squamous Cell Carcinoma
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028
What this trial is testing

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Who this might be right for
AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Testing effectiveness (Phase 2)Study completedNCT00093379
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Who this might be right for
Anal Cancer
M.D. Anderson Cancer Center 20
Not applicableEnded earlyNCT02140021
What this trial is testing

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenocarcinoma In SituCervical Intraepithelial Neoplasia+52 more
M.D. Anderson Cancer Center 409
Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29
Not applicableLooking for participantsNCT04094454
What this trial is testing

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy

Who this might be right for
Anal Cancer
Juergen Debus 60
Testing effectiveness (Phase 2)Ended earlyNCT00955240
What this trial is testing

Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer

Who this might be right for
Anal Cancer
UNICANCER 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04432597
What this trial is testing

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Who this might be right for
HPV Positive CancerVulvar, Vaginal, Penile, Rectal CancerAnal Cancer+2 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304545
What this trial is testing

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Who this might be right for
Rectal Cancer
Harbin Medical University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04287868
What this trial is testing

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Who this might be right for
Cervical CancerHPV CancersAnal Cancer+2 more
National Cancer Institute (NCI) 51
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166318
What this trial is testing

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma+3 more
ECOG-ACRIN Cancer Research Group 252
Load More Results